Conférences - Pharmacologie et développement des médicaments

SMi Group

As one of the most impactful pharmaceuticals for maintaining public health, antibiotics have been around since early 20th century and have since shown a need for significant progress in recent years. This is mainly due to its broad and indiscriminate use which has slowly given birth to multi- to extensively-drug resistant bacteria rendering our current last-resort antibiotic arsenal, including colistin, carbapenems, 3rd and 4th generation cephalosporins, useless. This year’s event aims to showcase a suite of sessions focused on novel drugs and approaches, particularly highlighting non-traditional and traditional therapies that provide an innovative means to spearhead the issue. The conference will also place significant emphasis on the much-needed support for innovative approaches such as sessions tackling the funding and support and the regulation that provides guidance towards the goal of ameliorating the continued rise of anti-microbial resistance AMR. It is crucial to bring industry leaders together to discuss the strategies in place that reduce AMR, evaluate the role pharmaceutical companies and funding bodies play in reducing AMR, learn about new diagnostics approaches to identify AMR and consider novel candidates and alternatives to anti-microbials. Join us in March 2020, along with leaders from the pharmaceutical industry, academia, regulatory and funding bodies, and public-private partnerships to discuss the way forward.

Announcement: Due to ongoing concerns over COVID-19 this conference is now available with remote access only – please register your place at www.superbugssuperdrugs.com/

Tél.: [02078276000];     Email.: events@smi-online.co.uk

Resistance; superbugs; superdrugs; mrsa; infectious diseases; investment; smart materials, infection, drug discovery, antibacterial, antimicrobial, anti-infective, multidrug resistance, MDR, diagnostics, immunization, inhibitors, antibiotic, resistance, antibiotic resistance, vaccine, bacterial, infections, drive a-b, genome sequencing, multi-resistant gram-negative, BARDA, Microbiota, EBOLA, bacteria, biotech, biomedical, pem, disease, amr, ppp, health, containment, microbiology, hepatitis, hcv, clinical, lab, gram positive, gram negative, fungi, fungal, population, contamination, viral, virus, amr, zika, fda, pathogen

Immunologie et Allergie,    Maladies Infectieuses

Learn to design a digital innovation strategy for Medical Affairs – Grasp the full power and trends of the whole spectrum of digital tactics that affect physicians and patients – Learn how to optimise the mix of tactics and to measure their business impact.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Corvus Global Events

The Annual Pharma Supply Chain and Security World Summit is back in London for the 3rd time, and this time with more focus on optimizing your supply chain challenges to ensure an agile, responsive, streamlined and secured supply chain. Pharmaceutical companies have to resist the challenges looming from supply chain security lapses to avoid infiltration of counterfeit, diverted, and adulterated drugs entering into the supply chain. To protect your brand and build a genuine future, Corvus Global Events invites you to Pharma Supply Chain & Security World 2020 - Supply-chain, Drug Serialization And Anti-Counterfeiting conference, which will have Pharma industry experts sharing various challenges faced, new strategies, case studies and use of innovative ideas, the conference will also offer opportunities to encourage partnerships and collaborations. In this conference you’ll not only discover innovative technologies, transformation strategies and collaboration methods, but how best to implement them to optimise your supply chain processes and strategies for drug anti-counterfeiting.

Corvus Global Events;     Tél.: [+442070960786];     Email.: info@corvusglobalevents.com

PharmaSecurityWorld, SupplyChain, counterfeitdrugs, Anticounterfeiting, BrandProtection, drugsecurity Serialization, Traceability, SupplyChain, IP, PharmaSupplyChain, Packaging, BrandEnforcement, BrandIntegrity, Labelling, Printing, TrackAndTrace, DrugRegulatory, RFID, fakedrugs

Learn and anticipate the market access challenges in rare diseases – Know how to leverage patient-centric real world evidence to accelerate the patient and market access of innovative and potentially transformative Orphan Medicinal Products (OMPs) and Advanced Therapy Medicinal Products (ATMPs) – Acquire planning tools that maximise product value of OMPs and ATMPs from launch to loss of exclusivity.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how medical affairs can enhance the commercial success of pharma brands with market insight generation, brand value definition, and HCP/patient engagement – Learn the critical success factors of a competitive medical affairs strategy and of an impactful tactical mix – Get familiar with the fundamentals of health economics and of leadership development.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

ITOC7 is organised by the WMA GmbH in scientific cooperation with the ITOC Association, the Tumor Centre in Munich (TZM), the Society for Immunotherapy of Cancer (SITC), the German Cancer Consortium (DKTK) as well as the Comprehensive Cancer Center Munic

The 7th Immunotherapy of Cancer Conference (ITOC7) to be held in Munich, Germany from April 2 – 4, 2020 is a European meeting providing a global platform for translational research in the field of immuno-oncology as well as a forum for discussion of early clinical translation and to address its unique challenges. The main goal of the series of ITOC conferences is to provide a unique platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and latest findings to advance the oncology drug development and delivery.

WMA GmbH Congress Office;     Tél.: [+431405138318];     Email.: itoc@medacad.org

Emerging concepts / novel agents Microbiome and immune system/immunotherapy Tumor microenvironment Vaccine Therapy Precision Medicine Meets Immunotherapy (Immuno-Monitoring) Cell Therapy in Solid Tumors Cell Therapy in Haematologic Diseases Combination Therapy

Cancérologie,    Immunologie et Allergie

BDG Lifesciences, India

We are glad to announce our 8th event in DUBAI which is a 1-Day Technical & Hands-on Workshop on Molecular Modelling in which we will cover Virtual Screening, Molecular Docking & Predictive Toxicology topics in Drug Design.

Workshops Coordinator;     Tél.: [+917017955472];     Email.: workshops@biodiscoverygroup.com

drugdiscovery, bioinformatics, bioinfo, itsdifferentbybiodiscovery, bdglifesciences, biotech, biotechnology, proteomics, dubai, uae, sharjah, abu dhabi, dubaidiaries, travelmiddleeast, gulf dubiotech

Cambridge Healthtech Institute

Cambridge Healthtech Institute's 15th Annual Drug Discovery Chemistry is a dynamic conference for medicinal chemists working in pharma and biotech. Focused on discovery and optimization challenges of small molecule drug candidates, Drug Discovery Chemistry provides many exciting opportunities for scientists to create a unique program to hear presentations most suited to one's personal interests by going back and forth among concurrent conferences. The 2020 event includes new coverage of RNA as a small molecule target, expanded coverage of artificial intelligence for early drug discovery, plus even more short courses to choose from.

Marketing Manager;     Email.: asaenger@healthtech.com

drug discovery, small molecules, therapeutics, medicinal chemistry

Complianceonline

Pharmaceutical dissolution testing helps to ensure the safety and efficacy of a variety of different formulated drug products. This three-day course covers the theory behind drug solubility and dissolution rate, regulatory expectations, experimental technique, interpretation of test results, investigating anomalous data, setting suitable dissolution specifications and the development and validation of dissolution tests. It also includes details of the USP and US FDA approaches for equipment qualification as well as the use of in vitro dissolution testing to establish bioequivalence. The establishment and uses of in vitro-in vivo correlations (IVIVC) will also be discussed.

Tél.: [18887172436];     Email.: referral@complianceonline.com

Pharmaceutical, Dissolution, Testing, ComplianceOnline

Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world – Know how to assess and calculate the value of a biotech company – Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Oxford Global

Tél.: [+441865248455];     Email.: e.hawkings@oxfordglobal.co.uk

Pharmaceutical, Drug Development, Formulation, Drug Delivery

Oxford Global

Meet and learn from experts in the biopharmaceutical manufacturing community to address critical strategic developments and technical innovation in continuous manufacturing & CMC, upstream & downstream process development and the manufacture of advanced therapeutics.

Tél.: [+441865248455];     Email.: e.hawkings@oxfordglobal.co.uk

Biomanufacturing, Upstream Bioprocessing, Downstream Bioprocessing, Biologics Manufacturing, Cell & Gene Therapy Manufacturing, Smart Factories, Digitalisation, CMC, Continuous Manufacturing

Complianceonline

The pharmacovigilance system master file (PSMF) is up-to-date comprehensive and dynamic document providing company employees (including regional or local Qualified Person for Pharmacovigilance, PV auditors etc) and the regulators with a detailed description of the entire PV system.

Tél.: [18003370077];     Email.: referral@complianceonline.com

pharmacovigilance system master file (PSMF), quality management system for PSMF maintenance, global PSMF design and implementation, PSMF example

Alzheimer's Drug Discovery Foundation

This interactive workshop is designed as an introductory course covering all aspects of drug discovery for neurodegenerative diseases, including Alzheimer’s, Parkinson’s, Huntington’s disease, Amyotrophic Lateral Sclerosis, Frontotemporal Degeneration, Multiple Sclerosis, ALS, FTD, MS. This unique workshop offers great opportunities to connect with key stakeholders from pharmaceutical, biotechnology, government and academic sectors. ADDF encourages young investigators, researchers from academia, bio-pharmaceutical and start-up organizations to submit their work for poster presentation. Application is open online through January 31, 2020. ADDF invites applications for the Young Investigator Travel Scholarships.

Event Secretariat;     Tél.: [224-938-9523];     Email.: meetings@alzdiscovery.org

drug discovery, neurodegeneration, Alzheimer's, Parkinson's, Huntington's disease, Amyotrophic Lateral Sclerosis, Frontotemporal Degeneration, Multiple Sclerosis

Oxford Global

Over 150 attendees working in peptides and oligonucleotides, representing global pharmaceutical organizations, leading biotech companies and internationally renowned academic institutions. Over 40 case studies, presentations and panel discussions focused on the key issues in peptide technologies, therapeutics case studies, discovery & development of oligonucleotide therapeutics, manufacturing and process development.

Tél.: [+441865248455];     Email.: b.copeman@oxfordglobal.co.uk

Peptide, Oligonucleotide, Peptide Chemistry, Peptide Characterisation, Peptide Purification, Peptide Discovery, Peptide Research, Antimicrobial Peptides, Peptide Synthesis, Peptide Manufacturing, Peptide Bioavailability, Peptide Toxicity, Peptide Process Development, Peptide Therapeutics, Peptide, Immunogenicity, Peptide Immunology, Peptide Stability, Peptide Automation, Peptide Half Life Extension, Peptide Novel Diseases, Peptide Endocrinology, Peptide Infectious Diseases, Peptide Oncology

Epigenetics is a field that impinges on many biological processes since it encompasses fundamental mechanisms of gene regulation. In addition, this area is currently exploited for drug development, particularly against cancer, since epigenetics regulators are miss-regulated in this disease. The conference will bring together all these themes. It will provide a comprehensive backdrop to the basic principles behind Epigenetic and cross-reference to their relevance to disease. There will be sessions on Chromatin, RNA and DNA regulatory pathways and a separate session on recent developments in drug discovery from Pharma.

Conference Manager;     Tél.: [00441638724137];     Email.: admin@fusion-conferences.com

Epigenetics, Cancer, Chromatin regulatory pathways, RNA modification pathways, DNA modification pathways, Drug discovery

Génomique et bio-informatique,    Cancérologie

Engineering Conferences International (ECI)

It is well known that the physical and chemical properties of the DS (API) have major impacts on the formulation and the Drug Product (DP) process. In any dosage form including solid, liquid and semi-solid, the Drug Substance (DS) or Active Pharmaceutical Ingredient (API) goes through a formulation process. This process to make the final drug product serves many purposes, but all with the goal of eventually delivering the active ingredient to the desired sites in the patients’ body in the most convenient way and to achieve optimal therapeutic effect.

Tél.: [2125146760];     Email.: noel@engconfintl.org

Role particle engineering process scaleup Pharmaceutical composite materials DS/DP interface integration DS (API)

CELforPharma

2 day training course delivered by David Wright & Pijush Bose. Learn how to uncover the unmet needs of strategic accounts and to develop patient-centric strategies that drive value for both your company, your account and patients – Know how to design and organise well-coordinated multi-functional account teams that result in much more effective KAM – Learn how to set up a KAM plan and to measure KAM success.

Director Commercial Communications;     Tél.: [+32 2 709 01 43];     Email.: inge.cornelis@celforpharma.com

How to develop patient-centric strategies that drive value for both your company, your account and patients. Approaches to uncover the unmet needs of Key Accounts. Analytical tools for discovering new growth opportunities within Key Accounts. How to prioritise triple-win opportunities for optimal value creation. What well-coordinated multi-functional account teams look like, and how such teams result in much more effective KAM. Best practices for setting Account Plan KPIs and for measuring Key Account success organisationally.

Learn how to engage patients with multi-channel disease awareness / patient activation campaigns – Know how to support patients in their therapy with multi-stakeholder / multi-channel patient adherence programmes – Be able to measure success and impact on the critical success factors of a patient-centric organisation.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the drivers of patient health behaviours – Learn how to identify and interpret specific individual drivers of health behaviours – Understand the practical steps to design/enhance your support solutions in a way that delivers true personalisation and support for all stakeholders - Take your current patient/caregiver/HCP support solution(s) to the next level with insights from Professor John Weinman and Nathan O’Donnell.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the role of MSLs within the organisation – Gain business acumen by understanding how the MSL can optimally add value to both external and internal stakeholders – Know how strategic decisions determine MSL tactics – Learn how to successfully plan and implement typical MSL tactics, and how to assess their impact – Discuss and discover how to deal with issues that MSLs typically are confronted with.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Complianceonline

Tél.: [18887172436];     Email.: referral@complianceonline.com

Cleanroom regulations, Cleanroom classifications, Cleanroom design considerations, Cleanroom qualification, Cleanroom cleaning validation IOQ/PQ, Cleanroom Routine Monitoring and Excursion Investigation, Cleanroom Environmental Monitoring Program, Environmental Monitoring Program, Cleanroom Monitoring, Excursion Investigation and Trending of Data, Cleanroom Personnel Training, Aseptic Practices, Cleanroom Behavior and Contamination Control Procedures, Cleanroom Trafficking, Cleanroom Gowning, Contamination Control, Cleaning and Disinfection Program, Sterilization Processes- Physical and Chemical Processes, basic concept of microbiology, microbiological and contamination control practices

Be able to decide on the best deal type for products in R&D – Know what to include in CDAs, MTAs and term sheets – Learn how to prepare product information and how to find potential partners – Know how to calculate the value of your product and optimise the deal structure.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Oxford Global

The events are aimed at VPs and senior directors of discovery in biology and chemistry from global pharmaceutical and biotech organisations. New for 2020, the event features focused R&D leaders sessions on Drug discovery Modalities and AI in drug development. It will also highlights successful strategies in delivering On Target Discovery, Phenotypic/Crispr Screening, Applications Of Organ-In-A Chip Platforms As Well As Tissue And 3D Culture For Disease Modelling. Empowering Drug Discovery with Chemical Biology, senior experts will also learn about enabling technologies that facilitate quicker drug development timelines such as protein degradation tools, target-based discovery techniques including RNA as novel targets. Do not miss out on cutting edge insights into computational chemistry and drug design methods.

Tél.: [+441865248455];     Email.: g.alonso@oxfordglobal.co.uk

Drug Discovery, Drug Design, Medicinal Chemistry

Médecine translationnelle, essais cliniques,    Biochimie et chimie médicale, toxicologie

Oxford Global

Oxford Global is proud to present our 2nd Annual Neuroscience Drug Discovery Congress, taking place 26 – 27 May 2020 in Berlin, Germany, which will bring together key leaders and influencers from global pharmaceutical organisations and leading academic research institutions. Discover the latest developments and critical approaches in neuroscience discovery, alongside cutting-edge enabling tools and technologies for developing neurological treatments. The congress encompasses the emerging trends and technological breakthroughs in drug discovery for neurodegenerative diseases, together with presentations on advancements in stem cell technologies to fuel drug discovery and iPS cells in disease modelling. On Day 2, we aim to emphasise the importance of targeted therapeutics and the crucial roles of biomarker development and gene therapy in drug discovery and translational neuroscience.

Key speakers include:

• Emilio Merlo Pich, Executive Director Neurology & Quantitative Medicine Neuroscience Therapeutic Area, Takeda

• Andreas Hartmann, Executive Director PreClinical Safety, Therapeutic Area Head, Novartis

• Ross Jeggo, Head of Research, Neuropsychiatry Centre for Therapeutic Innovation, Servier

View the Agenda: https://bit.ly/2rYH2kT

With over 20 unmissable presentations, the two-day congress offers an intuitive platform for high level scientific and business discussions, ensuring valuable networking and interactive sessions.

This events form part of the R&D Series EU and are co-located with our 21st Annual Drug Discovery Summit and 8th Annual Drug Design & Medicinal Chemistry Congress

For more information contact g.alonso@oxfordglobal.co.uk or visit the website: https://bit.ly/2PfND2z

Go Social: Join our Drug Discovery & Development Network on LinkedIn, follow us on Twitter @drugdiscovery1 and & join the conversation at #RNDSeries20

LIVE WEBINAR:

Predictive Model Approaches For Pharmacokinetics And Pharmacodynamics In CNS Discovery

Hosted by Elizabeth de Lange, Professor in Predictive Pharmacology, LACDR, Leiden University

Register (free): https://bit.ly/2RQHjBg

Tél.: [+441865248455];     Email.: g.alonso@oxfordglobal.co.uk

Neuroscience, Drug Discovery, Drug Development, Drug Design, Medicinal Chemistry

Learn how to design a digital marketing strategy for your brand, therapeutic area or company that integrates into the whole marketing mix – Grasp the full power and trends of all digital tactics in pharma – Learn how, and when, to select the appropriate tactics, optimise the mix and how to measure their business impact.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn and practice in role plays the whole armamentarium of winning strategies, tools, dos & don’ts, tricks & tips in each step of the pharma licensing negotiation process: planning – internal negotiations – making the first contact – term sheet assumptions – face-to-face meetings – resolving issues – contract closure.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Prepare for patent expiry with a winning LCM plan for established brands – Know which drivers of differentiation can be used – Learn where, when and how to compete in a generic world using late stage LCM strategies & tactics – Learn how to make portfolio management decisions for mature brands.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the terminology, tools, models and argumentation used in health economic evaluation articles – Learn to distinguish good from bad ones – Know how to integrate HECON studies into clinical & marketing plans – Learn how to use HECON evaluations towards healthcare payers.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how to analyse your brand’s market so that you discover all sales levers – Know how to determine priority segments and define a value positioning statement – Learn how to design the optimal mix of marketing tactics in both Red (highly competitive) & Blue (highly innovative) Ocean markets.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn the evidence-based concepts, models and techniques that work best to forecast the sales of pharmaceuticals – Know how to build Market Access into your forecasts – Learn to distinguish reliable from bad forecasts and how to forecast cost-effectively – Get practice with an Excel-based forecasting tool that integrates all the techniques taught.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Informa Markets In India

Launched in 2012, InnoPack Pharma Confex has been a premier platform for Pharmaceutical, Biopharmaceuticals & Healthcare packaging; drug delivery; machinery and medical devices. It has been successfully helping the industry to congregate, network, exchange ideas and knowledge, form alliances and shape the future of the industry, all under one roof.

The 2019 edition witnessed 55+ exhibiting companies and 900+ attendees from different regions. The Confex ensured the continuous engagement of the audience, speakers and exhibitors through various networking activities, workshop, round table discussion and an awards night dedicated to celebrate the Indian Pharma Packaging Industry.

The 2020 edition promises to benefit the attendees through its multiple opportunities focusing on developing valuable partnerships. This year the confex will witness the launch of new features like Solution Labs, Start-up Pavilion, Innovative Exhibitor Showcase, Technical Workshops, and a dedicated Scientific Conference which will ensure it caters to the entire value chain of the pharma packaging industry

Marketing Manager;     Tél.: [+91 98197 43776];     Email.: Meghna.Dekhtawala@ubm.com

Pharmaceutical, Packaging, Pharma, Manufacturing

CELforPharma

1 day training delivered by Michelle I Olufeso. Understand key financial and accounting terminology for licensing deals – Anticipate the financial/accounting implications of your decisions when assessing and negotiating licensing deals - Avoid the pitfalls caused by a lack of financial acumen in pharmaceutical licensing.

Director Commercial Communications;     Tél.: [+32 2 709 01 43];     Email.: inge.cornelis@celforpharma.com

The types of financial statements and their components relevant for deal accounting. To understand the accounting terminology and implications of licensing contracts. How the classification of the IP transferred in a deal impacts on deal accounting. How to mitigate the risk of having income fluctuations in financial statements as a result of uncertainty around R&D deals. How to determine the accounting implications of in-licensing deals before deal signing. How to determine the accounting implications of out-licensing deals before deal signing. The accounting implications of equity transfers before deal signing.

Understand the structure of the pharma business development process in the pharma-biotech world – Grasp the terminology, challenges, concepts & tools in each step, from analysis and planning... up to closing and following-up a deal – Be prepared for the financial and legal pitfalls.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the structure of the pharma business development process in the pharma-biotech world – Grasp the terminology, challenges, concepts & tools in each step, from analysis and planning... up to closing and following-up a deal – Be prepared for the financial and legal pitfalls.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand Market Access and grasp the structure of a healthcare system with its stakeholders – Learn the Market Access environment in Europe’s major markets – Know how to develop a Market Access Plan and how to communicate value to stakeholders.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Virtue Insight

This conference will provide an overview of global pricing, market access systems and cost management techniques, as well as in-depth discussion of some of the most current trends and changes. This Conference will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry. It will be studied with the help of case studies and industry experiences.Following a raft of health policy reforms impacting pharmaceutical pricing in almost every major country in the EU.

Email.: kavitha@virtueinsight.co.in

outcomes research, health economics, government affairs, pharma, pricing, reimbursement, market access, marketing, payer, heor, evidence, hta

Understand what HTA really means, the different types of HTAs across the EU and what can be expected from it – Learn the optimal HTA process and which criteria for assessment should be applied – Discover multiple solutions for optimising the quality of the evidence.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Master the critical success factors of a commercial drug launch: Selecting the right launch type – A structured roadmap – The critical market insights you need to gain in pre-launch phases – Identifying leverage points along the patient journey – Defining and prioritising customer segments - Designing the most effective omni-channel strategy and plan.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the language, the concepts and research techniques in pharmaceutical pricing – Learn how to set prices for optimal access and returns across Market Access systems, payer types and at different times of a product’s life cycle – Grasp the impact of international reference pricing and parallel trade, and how to deal with these.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

SMi Group

Following on the success of the 2019 West Coast event, SMi proudly presents the 4th Annual Pharmaceutical Microbiology West Coast Conference, in San Diego, USA, on June 18th and 19th 2020 bringing microbiology experts to focus on innovations in rapid methods and contamination control strategies. Microbes such as bacteria, fungi, parasites and viruses that can contaminate current and novel pharmaceutical products or therapies may stem from various sources such as raw materials and human operators, are taken into consideration.

Tél.: [02078276000];     Email.: ssapal@smi-online.co.uk

Pharmaceutical Microbiology, Contamination, Pharmaceuticals, Aseptic Technique, Sterility, Bioburden, Mycoplasma, Quality Control, Rapid Microbial Methods, Data Integrity, Risk Assessments, Environmental Monitoring, Microbiologist, Biofilms

CELforPharma

1 day training course delivered by Dr. Paul Craddy & Dr. Graham Foxon. Grasp the meaning, concepts, terminology, methodologies and research techniques of Real World Evidence (RWE) in the context of optimising Market Access - Know what each stakeholder type expects from RWE, which key data to use and how to develop a successful RWE study – Learn how to incorporate RWE into the product pre-launch process.

Director Commercial Communications;     Tél.: [+32 2 709 01 43];     Email.: inge.cornelis@celforpharma.com

The fundamental concepts and principles for utilising Real World Evidence (RWE) towards optimising Market Access. The value RWE adds over RCTs over a product’s entire lifecycle. The terminology used within the world of RWE, such as the exact difference between Real World Evidence and Real World Data (RWD). Why RWE is important to regulators, payers, physicians and pharma and how to tailor the evidence to their specific needs. The common sources of data available for RWE and how to assess the robustness of the data. The critical success factors when developing a RWE study. How to effectively incorporate RWE into product launch decisions.

The French Medicinal Chemistry Society (Société de Chimie Thérapeutique - SCT)

Interfacing Chemical Biology and Drug Discovery, Chemistry in living systems & Chemical biology for targets identification, Recent Advances in targeted Protein-Protein interactions including protein degradation and targeted protein-DNA/RNA interactions, Recent Trends in drug development for neurodegenerative diseases, Innovations in cancer therapeutics, Tackling new challenges in delivery systems and drug formulation, Case studies: moving new chemical entities to the market

This conference focuses on the design, synthesis and clinical validation of new drug delivery vehicles. This conference is designed to bridge the gap between basic science and unmet clinical needs.

Conference Manager;     Tél.: [00441638724137];     Email.: admin@fusion-conferences.com

Therapeutic gene editing, Extrahepatic delivery of nucleic acids, Characterization of therapeutic nanoparticles and control strategies for manufacturing, New linkers for triggered or controlled release, New long acting technologies, Tumor targeting with nanoparticles, recent progress and challenges

Pharmacogénétique, Médecine personnalisée,    Législation en médecine et pharmacologie

Biophysical Society (BPS)

Antibiotic resistance is a pressing global challenge to human health, and biophysics and bioengineering have much to offer to the global response to this challenge. This meeting will help bring together scientists working to diagnose, understand, and overcome antibiotic resistance. Engineering approaches and the biophysical methodologies of spectroscopy, single-molecule and single-cell microscopy, computational modeling, and development of functional assays are uniquely suited to help answer these questions. This meeting seeks to explore the interface between biophysical research and the microbiology of drug resistance, highlighting the breadth of work that spans these two fields and encouraging new synergies to tackle this global health problem.

Biophysique,    Biologie moléculaire

Zhenwei Exhibitions

Guangzhou International Biotechnology Conference&Expo will be held in September 2020. This event is jointly hosted by industry associations and Zhenwei Exhibition Group. The convention consists of six major sessions. More than a dozen of domestic and foreign business, academic, and political leaders will be invited to attend and discuss the hot topics and trends in the bio-industry chain, integrating policy orientation, market investment, technology research and development, and clinical applications.

Tél.: [+86 20 8395 3212];     Email.: yona_zhenweiexpo@126.com

Lab tech&Equipment Medical Lab&IVD Biopharma Ingredients Biotech Services Engineering Quality Management&Safety

Génie biomédical,    Cellules souches

Tél.: [+31887569555];     Email.: congress2020@ecnp.eu

brain disorder, health, neurology, pharma, mental disorder

Neurologie,    Psychiatrie

FISV is a non-profit organization whose aim is to coodinate the activities of scientific societies at national and international levels to promote the development of scientific research in Life Sciences. This year the congress edition has a drafted program aiming at fostering interdisciplinary exchange at the forefront of the life sciences spanning from the new genomic editing technology and precision medicine to sustainable agricultural approaches. Internationally renowned scientists from Italy and abroad will present their most recent data; in addition, the meeting will also allow several early career Italian and foreign scientists to present their research in a highly stimulating scientific environment. We will also have round tables on selected current topics as well as talks dedicated to a broader audience to enhance the interaction between scientists and non scientists. The FISV Congress will bring together scientists from across the world and will offer an invaluable opportunity to discuss scientific issues in the fields of Life Sciences. The congress will be opened to all researchers from Italy and abroad and will include a full range of academic sessions, plenary lectures, and social/cultural events. We plan to have talks by more than 30 invited speakers . Other researchers, mainly young researcher, will get an opportunity to showcase their work through the mini symposium sessions and during oral flash poster presentations.

Tél.: [00393392684792];     Email.: giulia.piaggio@ifo.gov.it

New technologies of genetic modification and biodiversity • Challenging Homo sapiens biounicity • New genomic technologies and biodiversity • The fall of human races, the many human species and their relationships • Diversity and evolution of genomes • From the plastics revolution to the bioplastics evolution • Insights into insect biology to control pathogen vectors and agricultural pests • Present and future of single cell studies • Microbiome modulation for improving human and plant health • Novel therapeutic targets for precision medicine

Biologie,    Biotechnologie

Complianceonline

This course is designed to cater for employees of pharmaceutical companies who would like an understanding of the drug development and regulatory approval process. The course starts by considering the global pharmaceutical market, important therapeutic areas and the roles of different pharmaceutical professionals in the development process, as well as a definition of drugs and medical devices. The drug development process, from discovery to post-marketing surveillance, is then explained. Topics include the identification of drug targets, synthesis of chemical drugs and the development of biologics, pharmacokinetics and toxicity screening, pre-clinical development, clinical studies, regulatory submissions, managing post-approval change, pharmacovigilance and an overview of regulations governing drug manufacture and distribution.

Tél.: [18887172436];     Email.: referral@complianceonline.com

Drug development process, identification of drug targets, synthesis of chemical drugs, the development of biologics, pharmacokinetics, toxicity screening, pre-clinical development, clinical studies, regulatory submissions, managing post-approval change, pharmacovigilance, governing drug manufacture and distribution fda regulations, global pharmaceutical market size

Learn to design a digital innovation strategy for Medical Affairs – Grasp the full power and trends of the whole spectrum of digital tactics that affect physicians and patients – Learn how to optimise the mix of tactics and to measure their business impact.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how to design a digital marketing strategy for your brand, therapeutic area or company that integrates into the whole marketing mix – Grasp the full power and trends of all digital tactics in pharma – Learn how, and when, to select the appropriate tactics, optimise the mix and how to measure their business impact.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Front Line Genomics

Real data. Real case studies. Real evidence. Real connections. D4 Europe is about finding the golden nuggets. Uncovering the truth. Benchmarking against other pharma. Learning from successes and failures. Understanding the context behind the results. Seeing the evidence – the actual data generated in projects. Getting past the headlines, into the substance. And importantly, understanding where you will see real, near term results in your pharma R&D. To achieve those things requires a more intimate meeting. One where you can meet and spend time with other attendees, as well as learn from the talks and discussions on the agenda. D4 Europe was designed by pharma, for pharma – a friendly gathering of around 120 people. It’s about bringing back tools, tactics and ideas that will make a difference to your drug discovery and development programs now. Not in 10 years’ time. Patients are waiting.

Events Team;     Tél.: [02081918810];     Email.: contact@frontlinegenomics.com

data, drug development, research, drug discovery, data science, drug design, fair data, pharma, ai, machine learning, data driven research

Understand the role of MSLs within the organisation – Gain business acumen by understanding how the MSL can optimally add value to both external and internal stakeholders – Know how strategic decisions determine MSL tactics – Learn how to successfully plan and implement typical MSL tactics, and how to assess their impact – Discuss and discover how to deal with issues that MSLs typically are confronted with.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how to engage patients with multi-channel disease awareness / patient activation campaigns – Know how to support patients in their therapy with multi-stakeholder / multi-channel patient adherence programmes – Be able to measure success and impact on the critical success factors of a patient-centric organisation.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn the evidence-based concepts, models and techniques that work best to forecast the sales of pharmaceuticals – Know how to build Market Access into your forecasts – Learn to distinguish reliable from bad forecasts and how to forecast cost-effectively – Get practice with an Excel-based forecasting tool that integrates all the techniques taught.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Biogate Scientific Center welcomes Vaccines Summit Ohio (VSOhio20) in Columbus, OH from October 05-07, 2020. VSOhio20 will cover a broad range of topics like animal models, clinical trials, big data, and analytics. The summit will bring together participants from around the globe, including high-level political decision-makers, health ministers, UN organizations, NGOs, academia representatives, renowned researchers and healthcare professionals, vaccine industry CEOs, celebrities and social media influencers who actively support vaccination.

Tél.: [+1 410 246 4289];     Email.: sachin@bsc.events

Vaccine Technology, Animal Models, Influenza Vaccines, Vaccine Safety Science, Regulatory Science, Clinical Evaluation, Nonclinical Development, Vaccine Hesitancy, Big data and Analytics

Master the critical success factors of a commercial drug launch: Selecting the right launch type – A structured roadmap – The critical market insights you need to gain in pre-launch phases – Identifying leverage points along the patient journey – Defining and prioritising customer segments - Designing the most effective omni-channel strategy and plan.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn and anticipate the market access challenges in rare diseases – Know how to leverage patient-centric real world evidence to accelerate the patient and market access of innovative and potentially transformative Orphan Medicinal Products (OMPs) and Advanced Therapy Medicinal Products (ATMPs) – Acquire planning tools that maximise product value of OMPs and ATMPs from launch to loss of exclusivity.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the terminology, tools, models and argumentation used in health economic evaluation articles – Learn to distinguish good from bad ones – Know how to integrate HECON studies into clinical & marketing plans – Learn how to use HECON evaluations towards healthcare payers.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

CELforPharma

1 day training course delivered by Dr. Paul Craddy & Dr. Graham Foxon. Grasp the meaning, concepts, terminology, methodologies and research techniques of Real World Evidence (RWE) in the context of optimising Market Access - Know what each stakeholder type expects from RWE, which key data to use and how to develop a successful RWE study – Learn how to incorporate RWE into the product pre-launch process.

Director Commercial Communications;     Tél.: [+32 2 709 01 43];     Email.: inge.cornelis@celforpharma.com

The fundamental concepts and principles for utilising Real World Evidence (RWE) towards optimising Market Access. The value RWE adds over RCTs over a product’s entire lifecycle. The terminology used within the world of RWE, such as the exact difference between Real World Evidence and Real World Data (RWD). Why RWE is important to regulators, payers, physicians and pharma and how to tailor the evidence to their specific needs. The common sources of data available for RWE and how to assess the robustness of the data. The critical success factors when developing a RWE study. How to effectively incorporate RWE into product launch decisions.

Understand Market Access and grasp the structure of a healthcare system with its stakeholders – Learn the Market Access environment in Europe’s major markets – Know how to develop a Market Access Plan and how to communicate value to stakeholders.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how medical affairs can enhance the commercial success of pharma brands with market insight generation, brand value definition, and HCP/patient engagement – Learn the critical success factors of a competitive medical affairs strategy and of an impactful tactical mix – Get familiar with the fundamentals of health economics and of leadership development.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the language, the concepts and research techniques in pharmaceutical pricing – Learn how to set prices for optimal access and returns across Market Access systems, payer types and at different times of a product’s life cycle – Grasp the impact of international reference pricing and parallel trade, and how to deal with these.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Prepare for patent expiry with a winning LCM plan for established brands – Know which drivers of differentiation can be used – Learn where, when and how to compete in a generic world using late stage LCM strategies & tactics – Learn how to make portfolio management decisions for mature brands.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand what HTA really means, the different types of HTAs across the EU and what can be expected from it – Learn the optimal HTA process and which criteria for assessment should be applied – Discover multiple solutions for optimising the quality of the evidence.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how to engage patients with multi-channel disease awareness / patient activation campaigns – Know how to support patients in their therapy with multi-stakeholder / multi-channel patient adherence programmes – Be able to measure success and impact on the critical success factors of a patient-centric organisation.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how to analyse your brand’s market so that you discover all sales levers – Know how to determine priority segments and define a value positioning statement – Learn how to design the optimal mix of marketing tactics in both Red (highly competitive) & Blue (highly innovative) Ocean markets.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

CELforPharma

2 day training course delivered by David Wright & Pijush Bose. Learn how to uncover the unmet needs of strategic accounts and to develop patient-centric strategies that drive value for both your company, your account and patients – Know how to design and organise well-coordinated multi-functional account teams that result in much more effective KAM – Learn how to set up a KAM plan and to measure KAM success.

Director Commercial Communications;     Tél.: [+32 2 709 01 43];     Email.: inge.cornelis@celforpharma.com

How to develop patient-centric strategies that drive value for both your company, your account and patients. Approaches to uncover the unmet needs of Key Accounts. Analytical tools for discovering new growth opportunities within Key Accounts. How to prioritise triple-win opportunities for optimal value creation. What well-coordinated multi-functional account teams look like, and how such teams result in much more effective KAM. Best practices for setting Account Plan KPIs and for measuring Key Account success organisationally.

Understand the marketing principles that determine a pharmaceutical’s commercial success - Learn how your function can contribute to a pharma brand’s success in the new environment - Know how pharma marketers take strategic and tactical decisions - Gain ideas for cross-functional synergies that benefit a brand’s success.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn and practice in role plays the whole armamentarium of winning strategies, tools, dos & don’ts, tricks & tips in each step of the pharma licensing negotiation process: planning – internal negotiations – making the first contact – term sheet assumptions – face-to-face meetings – resolving issues – contract closure.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn and anticipate the market access challenges in rare diseases – Know how to leverage patient-centric real world evidence to accelerate the patient and market access of innovative and potentially transformative Orphan Medicinal Products (OMPs) and Advanced Therapy Medicinal Products (ATMPs) – Acquire planning tools that maximise product value of OMPs and ATMPs from launch to loss of exclusivity.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the drivers of patient health behaviours – Learn how to identify and interpret specific individual drivers of health behaviours – Understand the practical steps to design/enhance your support solutions in a way that delivers true personalisation and support for all stakeholders - Take your current patient/caregiver/HCP support solution(s) to the next level with insights from Professor John Weinman and Nathan O’Donnell.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world – Know how to assess and calculate the value of a biotech company – Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the role of MSLs within the organisation – Gain business acumen by understanding how the MSL can optimally add value to both external and internal stakeholders – Know how strategic decisions determine MSL tactics – Learn how to successfully plan and implement typical MSL tactics, and how to assess their impact – Discuss and discover how to deal with issues that MSLs typically are confronted with.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Be able to decide on the best deal type for products in R&D – Know what to include in CDAs, MTAs and term sheets – Learn how to prepare product information and how to find potential partners – Know how to calculate the value of your product and optimise the deal structure.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand Market Access and grasp the structure of a healthcare system with its stakeholders – Learn the Market Access environment in Europe’s major markets – Know how to develop a Market Access Plan and how to communicate value to stakeholders.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how medical affairs can enhance the commercial success of pharma brands with market insight generation, brand value definition, and HCP/patient engagement – Learn the critical success factors of a competitive medical affairs strategy and of an impactful tactical mix – Get familiar with the fundamentals of health economics and of leadership development.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the language, the concepts and research techniques in pharmaceutical pricing – Learn how to set prices for optimal access and returns across Market Access systems, payer types and at different times of a product’s life cycle – Grasp the impact of international reference pricing and parallel trade, and how to deal with these.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the terminology, tools, models and argumentation used in health economic evaluation articles – Learn to distinguish good from bad ones – Know how to integrate HECON studies into clinical & marketing plans – Learn how to use HECON evaluations towards healthcare payers.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn to design a digital innovation strategy for Medical Affairs – Grasp the full power and trends of the whole spectrum of digital tactics that affect physicians and patients – Learn how to optimise the mix of tactics and to measure their business impact.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how to design a digital marketing strategy for your brand, therapeutic area or company that integrates into the whole marketing mix – Grasp the full power and trends of all digital tactics in pharma – Learn how, and when, to select the appropriate tactics, optimise the mix and how to measure their business impact.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the structure of the pharma business development process in the pharma-biotech world – Grasp the terminology, challenges, concepts & tools in each step, from analysis and planning... up to closing and following-up a deal – Be prepared for the financial and legal pitfalls.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Master the critical success factors of a commercial drug launch: Selecting the right launch type – A structured roadmap – The critical market insights you need to gain in pre-launch phases – Identifying leverage points along the patient journey – Defining and prioritising customer segments - Designing the most effective omni-channel strategy and plan.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn the evidence-based concepts, models and techniques that work best to forecast the sales of pharmaceuticals – Know how to build Market Access into your forecasts – Learn to distinguish reliable from bad forecasts and how to forecast cost-effectively – Get practice with an Excel-based forecasting tool that integrates all the techniques taught.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com